| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/05/2006 | CA2593559A1 Polynucleotides encoding stem cell factor-like proteins |
| 10/04/2006 | EP1707631A2 An improved method for the production and purification of adenoviral vectors |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1707225A2 Methods and compositions for treating intervertebral disc degeneration |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1706492A2 Materials and methods relating to cell cycle control |
| 10/04/2006 | EP1706421A2 Methods of modulating cytokine activity; related reagents |
| 10/04/2006 | EP1706416A2 Chimera botulinum toxin type e |
| 10/04/2006 | EP1706176A2 Frequency assisted transdermal agent delivery method and system |
| 10/04/2006 | EP1706150A1 Stable growth hormone liquid formulation |
| 10/04/2006 | EP1706146A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 10/04/2006 | EP1706144A2 Medicament comprising inhibitors of long pentraxin ptx3 |
| 10/04/2006 | EP1706141A1 Methods of using botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion) |
| 10/04/2006 | EP1706139A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis |
| 10/04/2006 | EP1706138A2 Methods for treating inflammation using thyroid stimulating hormone |
| 10/04/2006 | EP1706137A2 M-csf muteins and uses thereof |
| 10/04/2006 | EP1706136A2 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 10/04/2006 | EP1706135A1 A treatment for necrotizing enterocolitis |
| 10/04/2006 | EP1706134A2 Use of protein products for preventing and treating pancreatic diseases and/or obestiy and/or metabolic syndrome |
| 10/04/2006 | EP1706133A2 Methods of protecting against radiation using flagellin |
| 10/04/2006 | EP1706132A1 A composition for cartilage therapeutics and using method thereof |
| 10/04/2006 | EP1706131A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 10/04/2006 | EP1706130A2 Matrix array nanobiosensor |
| 10/04/2006 | EP1706129A1 Drug therapy for celiac sprue |
| 10/04/2006 | EP1706128A1 Pharmaceutical compositions and methods for insulin treatment |
| 10/04/2006 | EP1668358A4 Reconstitution medium for protein and peptide formulations |
| 10/04/2006 | EP1638588B1 P-selectin targeting ligand and compositions thereof |
| 10/04/2006 | EP1467746A4 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue |
| 10/04/2006 | EP1412328B1 Dolastatin 10 derivatives |
| 10/04/2006 | EP1311691B1 Method and compositions for promoting osteogenesis |
| 10/04/2006 | EP1255827B1 Oligonucleotides and their use for modulating the expression of tyrosinase involved in the synthesis of melanic pigments |
| 10/04/2006 | EP1253945B1 Ace inhibitor-vasopressin antagonist combinations |
| 10/04/2006 | EP1157101B1 Drug design based on the three-dimensional structure of lta4 hydrolase |
| 10/04/2006 | EP1143931B1 Pulmonary drug delivery |
| 10/04/2006 | EP1135513B1 Adenovirus-mediated gene therapy |
| 10/04/2006 | EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof |
| 10/04/2006 | EP1003861B1 Mammalian cell membrane proteins; related reagents |
| 10/04/2006 | EP0986644B1 Production of erythropoietin by endogenous gene activation with viral promoters |
| 10/04/2006 | EP0977873B1 Method for cleavage of fusion proteins |
| 10/04/2006 | EP0964702B1 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
| 10/04/2006 | EP0783525B1 Humanized antibodies against respiratory syncytial virus |
| 10/04/2006 | CN1842349A Gene therapy for skin diseases using needle free syringe |
| 10/04/2006 | CN1842348A Galactomannans and/or glucomannans for increasing the bioavailability of active substances |
| 10/04/2006 | CN1842346A Regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 10/04/2006 | CN1842344A Use of human fibrinogen a alpha or b beta chain peptide for treating shock |
| 10/04/2006 | CN1842343A Use of modified cyclosporins for the treatment of hcv disorders |
| 10/04/2006 | CN1842342A Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
| 10/04/2006 | CN1841106A Cam ring |
| 10/04/2006 | CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 10/04/2006 | CN1840680A Double-enzyme process for modification preparation of injection type soybean protein isolate |
| 10/04/2006 | CN1840665A Virulence genes, proteins, and their use |
| 10/04/2006 | CN1840659A Method of treating endotoxemia |
| 10/04/2006 | CN1840545A Human tumor cell growth associated protein and splice variant and coding gene thereof |
| 10/04/2006 | CN1840544A ESC42 protein, preparation method and use thereof |
| 10/04/2006 | CN1840541A Helicobacter pylori protein and its preparing method and use |
| 10/04/2006 | CN1840195A A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 10/04/2006 | CN1840194A Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/04/2006 | CN1840187A Method for preparing highly-active thrombin inhibitor |
| 10/04/2006 | CN1840186A Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 10/04/2006 | CN1840185A Brain-caring compound tablet, its preparation process and quality control method |
| 10/04/2006 | CN1840184A Lysozyme liposome and preparation method thereof |
| 10/04/2006 | CN1840183A Use of sphingomyelinase for increasing the levels of skin and mucosal ceramides |
| 10/04/2006 | CN1840182A Application of N-acetylmuramide glycanohydrla in treatment of AIDS |
| 10/04/2006 | CN1840181A Therapeutic use of selective PDE10 inhibitors |
| 10/04/2006 | CN1840180A Application of bovine lactoferricin in preparation of medicine for treating gastric disease and reducing secretion of gastric acid |
| 10/04/2006 | CN1840179A Application of bovine lactoferricin in preparation of medicine for treating HP infected gastric disease |
| 10/04/2006 | CN1840178A Tumour-specific animal proteins |
| 10/04/2006 | CN1840177A Injection liquid of thymic peptide alpha 1 and preparation method thereof |
| 10/04/2006 | CN1840176A Sublingual tablet of natural hirudin |
| 10/04/2006 | CN1840175A Ointment of natural hirudin |
| 10/04/2006 | CN1840174A Application of polygonatum cyrtonema Hua. Lectin II protein in medicine preparation for treating or preventing AIDS |
| 10/04/2006 | CN1840173A Infusion liquid for treating cow mastitis and preparation method thereof |
| 10/04/2006 | CN1840172A Pidotimod solution capable of being administered from vein |
| 10/04/2006 | CN1840171A Nutrition liquid for chronic nephropathy and preparation method thereof |
| 10/04/2006 | CN1839799A Agglutinin-modified drug delivery system from nose to brain |
| 10/04/2006 | CN1277925C Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof |
| 10/04/2006 | CN1277918C Method for producing super oxide mutase complex enzyne at large scale using grain seed |
| 10/04/2006 | CN1277917C CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 10/04/2006 | CN1277844C Novel human cyclin, its coding sequence and application |
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/04/2006 | CN1277581C Method for producing antithrombotic medicine by using silk-worm |
| 10/04/2006 | CN1277580C Use of chemical synthetic antifungal disome peptide for treating pathogenic fungus infection |
| 10/04/2006 | CN1277537C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
| 10/03/2006 | USRE39321 Expanding fibrin sealant foam for treating wounded tissue in a patient comprising fibrinogen, derivative or metabolite which forms a fibrin matrix; wound healing agents; dressings |
| 10/03/2006 | US7117516 Method and system for providing a customized media list |
| 10/03/2006 | US7117096 Structure-based selection and affinity maturation of antibody library |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 |
| 10/03/2006 | US7115728 Adipocyte differentiation; obesity |
| 10/03/2006 | US7115727 Comprise oligopeptide for diagnosis, prognosis, prevention and treatment of tumors/cancer |
| 10/03/2006 | US7115715 Oncogenic protein for use in the diagnosis and treatment of tumors |
| 10/03/2006 | US7115713 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 10/03/2006 | US7115712 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12 |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115663 Increased or improved bioavailability of the active agent |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |
| 10/03/2006 | US7115626 Treatment of cardiovascular and related pathologies |
| 10/03/2006 | US7115625 Administering mixtures of pyridoxal-5'-phosphate, pyridoxal, pyridoxamine, and analogues, angiotensin converting enzyme inhibitors, angiotensin receptor antagonists, vasodilators and diuretics, for prophylaxis of congestive heart failure |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |